President Joe Biden’s cancer moonshot is expanding abroad. On September 21, 2024, Biden announced a collaboration between the United States, Australia, India, and Japan to fight cervical cancer in the Indo-Pacific at a summit in Delaware on Saturday. Cervical cancer, caused by human papillomavirus infection, is the fourth most common cancer in people with a cervix globally, killing an estimated 350,000 in 2022, according to the World Health Organization. In the Indo-Pacific, cervical cancer is the third leading cause of death in individuals with a cervix.
ONS Perspective
Preventing cancer before it begins is a priority that ONS shares with the Cancer Moonshot. Cervical cancer is one of the most common—and deadliest—cancers around the world, but human papillomavirus (HPV) vaccination is nearly 100% effective in preventing the virus that causes the disease. Oncology nurses have a global opportunity to advocate for awareness and access to this lifesaving vaccine.
As an active supporter of the Cancer Moonshot since its inception, ONS is a member of the HPV Cancers Alliance, working to promote HPV vaccination and eliminate cervical and other HPV-related cancers. The Alliance has engaged with White House staff on this issue, and ONS hosted a webinar to highlight the importance of HPV vaccination in August 2024. Through these collaborative efforts, ONS and its oncology nurse advocates are advancing cancer prevention and ensuring better health outcomes for all. Learn how you can get involved.
Additional Articles of Interest
- Affordable Care Act May Increase Access to Colon Cancer Care for Underserved Groups
- Alcohol Plays a Key Role in Cancer Risk, New Expert Report Warns
- Breast Cancer Awareness Month: Woman Turns Personal Battle Into Advocacy
- Congress Approves Funding Bill to Avoid Government Shutdown
- GOP Lawmakers Fear Trump Will Renew War Over Obamacare